© 2011 Global Genes Project 2011-07 r8 R.A.R.E Project presents – The RARE Fund.

Slides:



Advertisements
Similar presentations
1 Increasing Biotech Involvement in Global Health Innovation Oxford Conference on Innovation and Technology Transfer for Global Health September 11, 2007.
Advertisements

IFAD’s regional communication strategy for Western and Central Africa.
February 27, 2014 Margaret Anderson Executive Director, FasterCures The Evolving Role of Patients in the R&D Ecosystem.
GLOBAL PHILANTHROPY Trends in International Giving – An Opportunity for Professional Advisors STEP Bermuda February 2013.
PRSA Student of the Year Competition. Introduction I approached this project as a patient looking for information on community service programs. By surveying.
Advocating for Your Cause and National Literacy Action Week Student Coalition for Action in Literacy Education (SCALE) 1.
THE WISDOM TRUST. Agenda 1.About Us 2.Mission 3.Live With A Bit More Wisdom 4.Donations To Charities 5.Grants For Individuals 6.Media Projects 7.Communities.
Redefining Partnership & Creating Opportunity for All Brian A. Gallagher President and CEO United Way Worldwide October 28, 2014 United Way Roundtable.
Centre for Health & Technology Maritta Perälä-Heape, PhD Director, CHT.
[ Date ] [insert your community foundation logo here] Give Local America A giving day opportunity.
Country Action Plan REPUBLIC OF GHANA. Strategic Agenda Value Proposition – Stimulating growth and employment which hinges on a knowledge based economy.
Global Health Program Guiding Principles April 2002.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Delivering practical solutions
Rebecca Mauger Head of High Value Giving, British Red Cross Finding.
National Year of Reading “I am announcing a National Year of Reading – ten years on from the first Year of Reading – which I hope will bring about.
The Academia-Industry Marriage: How to get the I do! The Promise of Innovation Montserrat Capdevila Director of Sales, Marketing, and International Relations.
Do not distribute. Disease affecting < 1/2.000 citizens (EU) Disease affecting < citizens (US) > different orphan diseases < 500 drugs approved.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
Leveraging Patient Engagement & the Role of Advocacy.
The Infectious Diseases Institute Kampala, Uganda InfoPoverty World Conference United Nations InfoPoverty World Conference United Nations Robert L. Mallett.
Modern Philanthropy Dawn Carr, BBCCF Third Sector Assembly BVSC.
Members Meeting WINGSForum 2014 March 29, 2014 Istanbul, Turkey
Demystifying Fundraising And what’s in it for you! Janet Turcot Vukovic Senior Development Officer Faculty of Health HNES403
© Crown copyright Met Office Open Platform and ACRE
1 The Lockheed Martin India Innovation Growth Program
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
October 2009 From the American People…. Total U.S. Assistance to Serbia from : $716 Million (USAID: $545 million) Mission Statement: USAID programs.
June 2009 World Hospice and Palliative Care Day Discovering your voice.
The Networking a great communication opportunity for nonprofit Dissertation of Chiara Porqueddu Supervisor Giampaolo Azzoni Co-supervisor Marco Dotti.
What is Education?. By Education - Mahatma Gandhi BodyMindand Spirit I mean the all round drawing out of.
Summary of the U.S. Task Force on United Way’s Economic Model & Growth.
Best Practices in the European Angel Investment Ecosystem Baybars Altuntas, Vice President.
Ibero-American Road Safety Conference Madrid, February 23-24, World Bank Global Road Safety Facility.
Advocacy and Philanthropy: Creating Social Impact JOHN FINKENBERG MD PRESIDENT NATIONAL ASSOCIATION OF SPINE SPECIALISTS ADVOCACY COUNCIL CHAIRMAN NASS.
Creating Entrepreneurial Communities: The ideal conditions to unleash the potential of next generation leaders Christopher Gergen.
VCOSS Congress August Philanthropy Australia What do we do? Philanthropy Australia is the national peak body for philanthropy and is a non-profit.
RARE / ORPHAN DISEASES “ARE WE READY FOR THE CHANGE THAT WE NEED TO FIND EFFECTIVE TREATMENTS FOR ORPHAN DISEASE?”
PUTTING THE PATIENT AT THE CENTER OF HEALTHCARE RESEARCH Towards a more inclusive model.
1/14 White Paper, “A Strategy for Europe on Nutrition, Overweight and Obesity related Health Issues” Platform Plenary 4 July 2007 Ceri Thompson Directorate-General.
Accelerating Evidence-based Action in Cancer Control and Facilitating Virtual Collaboration in Canada through Cancerview.ca International Cancer Control.
AAI Fundraising Project For Globalgiving.org. Open Challenge Fundraising on Globalgiving.org 4 weeks(2 August-31 August) Minimum Fundraising goal: $4000.
Highlights of National and International IPY Activities Chris Elfring, Director Polar Research Board of the National Academies U.S. National Committee.
CREATING A ROADMAP FOR FINDING VALUE IN FOOD WASTE REDUCTION November 17,
PRESENTATION TITLE | DATE Public Policies Impacting the Life Science Ecosystem.
Arizona Gives Day. What is Arizona Gives Day? Background of Arizona Gives Day 2013 Campaign Results Thinking about 2014.
An Introduction to Genetic Alliance UK’s Work in Scotland Natalie Frankish – Development Officer for Scotland Event:Action Duchenne Scottish Conference.
Making My Mark Volunteering through Watermark DATE By: [Presenter Name/Title]
Crowdfunding describes the collective cooperation, attention and trust by people who network and pool their money and other resources together, usually.
Crowdfunding for MGH Researchers MGH Research Council Meeting Monday, December 7, 2015.
Centers of Excellence in Health A permanent approach to improving health systems in Africa Transforming Africa’s health systems… from within.
Climate Change Impacts and Adaptation: The Prairie Adaptation Research Cooperative Mark Johnston Forest Ecosystems Branch, Environment and Resource Management.
The Solution: Foundation for Patient Powered Solutions Deploy a shared enterprise solution that will empower patient advocacy organizations to share in.
1. Page 2 What is the One Billion Coalition? 2 The One Billion Coalition is… A broad coalition of individuals, communities, and organisations Leveraging.
Gwendolyn Ryals, Look at Me Artwork from The Creative Center Janey Shin, Director, Real World Evidence Government Affairs and Market Access CADTH Symposium.
Engaging Community & Donors to Support Youth All In for Youth, United Way Calgary & Area United Way Worldwide, Community Leaders Conference May 2016.
Patient Engagement throughout the Biopharmaceutical Lifecycle: Tips for Effective Patient Advocate/Industry Collaboration to Improve Patient Access and.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
G20 GLOBAL PLATFORM ON INCLUSIVE BUSINESS (GPIB) OFFICIAL LAUNCH & WORKSHOP SESSION 1 APRIL 6, 2016.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved U.S. Digital Genome Market share accounted for over 80% of the North American revenue in 2015.
© Coherent market Insights. All Rights Reserved PEDIATRIC CLINICAL TRIALS MARKET Global Industry Insights, Outlook Size, Share and Opportunity Analysis,
End of year fundraising tips
National and International Efforts worth knowing about
Research Overview Jacqueline French, MD Chief Scientific Officer
Finland, a Global Testbed for Personalized Cancer Research?
Engaging audiences, understanding motivations and winning support
Trial Funding and Engagement: The NIH Sponsored CTSA Program
The Network of European Patient Advocacy Groups is the only umbrella organization for patient groups committed to gynaecological cancers. Established in.
Advocacy 101 Kristen Angell, Associate Director of Advocacy
ADVANCING THE PRACTICE OF CASE MANAGEMENT
Presentation transcript:

© 2011 Global Genes Project r8 R.A.R.E Project presents – The RARE Fund

RARE is not so RARE US Only living with Rare Disease 35m US Only living with Rare Disease 35m Worldwide living with cancer 28m Worldwide living with cancer 28m US Only - living with HIV/AIDS 1.2m

RARE is not so RARE US Only –7,000 RARE Diseases – 1 in 10 Americans – 350M worldwide –7,000 RARE Diseases – 1 in 10 Americans – 350M worldwide

The Problem Over 80% of Rare Diseases have no disease-specific advocacy group or support Over past 25+ years, only 350 new drugs approved by FDA for all Rare Diseases combined Rare Disease early research funded by patient advocates/advocacy groups Currently Rare Disease funding is limited to small networks of families and friends No catalyst for new investment!

The Solution – Awareness & Money RARE Fund™ - Two Facets Micro-donation website and funding portal – Broad public appeal – Gives general public an opportunity to donate – Modeled after successful micro-funding platforms; Razoo.com, crowdrise.com, giveforward.org, broadcause.com – Create opportunity to tap ‘new money, new philanthropists’ Corporate Fund & Global Genes Project Campaign – Provides opportunity for corporations to fund research – Impact on 1 in 10 Americans (350 million) is attractive – First time opportunity to fund ‘rare disease’research

R.A.R.E FUND ™

R.A.R.E FUND ™ Micro-Donation Website A novel approach to raising funds – Contemporary, multi-faceted, and engaging Open, trusting, and transparent – Facilitate broad general public donor involvement Presenting Research – Lay view and Research view Engaging new generation of philanthropists Catalyzing excitement around innovations in science

R.A.R.E. FUND ™ - General Emphasis on improving the Rare Disease ecosystem – Generate/organize research profiles & disease databases – Fund peer reviewed cross-disease projects & infrastructure – Impact policy, collaboration, and process Fund Innovations – with ‘in-their-lifetime’ impact Focus: To accelerate process, increase collaborations and improve efficiencies

R.A.R.E. Project R.A.R.E. Projects three pronged strategy: – Awareness & education – Community-building and empowerment – Funding in-their-lifetime Rare Disease research Supported by: – Industry: Pfizer, Life Technologies, Illumina, Shire, Genzyme, BioMarin, BIO, PhRMA, NIH, etc – Advocacy: 450+ global organizations Acitivities: – Global Genes Project™, Childrens RARE Disease Network™, RARE Blog™, RARE Fund™

Contact Information Nicole Boice Founder/President RARE Project (RARE)